List of China Pharmaceutical University patents

Patents where

Current Assignee

Name

China Pharmaceutical University

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11504385 Proteolysis targeting chimeric molecule, preparation method, and application	Patent 11504385 was granted and assigned to China Pharmaceutical University on November, 2022 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11504385	November 22, 2022
‌ US Patent 11541032 Composition containing sumo inhibitor and application	Patent 11541032 was granted and assigned to China Pharmaceutical University on January, 2023 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11541032	January 3, 2023
‌ US Patent 11304926 Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis	Patent 11304926 was granted and assigned to China Pharmaceutical University on April, 2022 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11304926	April 19, 2022
‌ US Patent 11572359 PARP/PI3K double-target inhibit containing pyridopyrimidine structure			China Pharmaceutical University	United States Patent and Trademark Office	11572359	February 7, 2023
‌ US Patent 11479545 Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction	Patent 11479545 was granted and assigned to China Pharmaceutical University on October, 2022 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11479545	October 25, 2022
‌ US Patent 10526370 Pentapeptide associated with integrin receptor alpha vbeta3	Patent 10526370 was granted and assigned to China Pharmaceutical University on January, 2020 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	10526370	January 7, 2020
‌ US Patent 9822089 R type of resveratrol dimer, preparation process therefor and purpose thereof in lowering blood sugar level	Patent 9822089 was granted and assigned to China Pharmaceutical University on November, 2017 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	9822089	November 21, 2017
‌ US Patent 11242340 Crystal forms of demethyleneberberine hydrochloride and preparation method therefor	Patent 11242340 was granted and assigned to China Pharmaceutical University on February, 2022 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11242340	February 8, 2022
‌ US Patent 7772230 Chroman compound, processes for its preparation, and its pharmaceutical use	Patent 7772230 was granted and assigned to China Pharmaceutical University on August, 2010 by the United States Patent and Trademark Office.		China Pharmaceutical University	United States Patent and Trademark Office	7772230	August 10, 2010
‌ US Patent 11021454 Type of aryl benzofuran amidated derivative and medical use thereof	Patent 11021454 was granted and assigned to China Pharmaceutical University on June, 2021 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11021454	June 1, 2021
‌ US Patent 11078250 High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof	Patent 11078250 was granted and assigned to China Pharmaceutical University on August, 2021 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11078250	August 3, 2021
‌ US Patent 11014895 Heterocyclic urea compound, and drug composition and application thereof	Patent 11014895 was granted and assigned to China Pharmaceutical University on May, 2021 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11014895	May 25, 2021
‌ US Patent 9943524 Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis	Patent 9943524 was granted and assigned to China Pharmaceutical University on April, 2018 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	9943524	April 17, 2018
‌ US Patent 10875903 Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof		China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	10875903	December 29, 2020
‌ US Patent 10639289 Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction		China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	10639289	May 5, 2020
‌ US Patent 11085022 Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof	Patent 11085022 was granted and assigned to China Pharmaceutical University on August, 2021 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11085022	August 10, 2021
‌ US Patent 10442759 1-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereof	Patent 10442759 was granted and assigned to China Pharmaceutical University on October, 2019 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	10442759	October 15, 2019
‌ US Patent 8501803 None			China Pharmaceutical University	United States Patent and Trademark Office	8501803	August 6, 2013
‌ US Patent 11905230 Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament	Patent 11905230 was granted and assigned to China Pharmaceutical University on February, 2024 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11905230	February 20, 2024
‌ US Patent 11970523 Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof	Patent 11970523 was granted and assigned to China Pharmaceutical University on April, 2024 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11970523	April 30, 2024
‌ US Patent 11773057 Naphthalenesulfonamide compound, preparation method, and application	Patent 11773057 was granted and assigned to China Pharmaceutical University on October, 2023 by the United States Patent and Trademark Office.	China Pharmaceutical University	China Pharmaceutical University	United States Patent and Trademark Office	11773057	October 3, 2023

21 results

0 selected

21 results

0 selected